Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients

Present: The affiliation information is incomplete.

Correct: Additional affiliation information is shown below. The publishers sincerely apologize for this oversight.

Original article: Oncotarget. 2017; 8:11173-11186. https://doi.org/10.18632/oncotarget.14491

Lourdes Hontecillas-Prieto^1,*, Daniel J. Garcia-Dominguez^1,*, Diego Pascual Vaca², Rosa Garcia-Mejias¹, David Marcilla², Gema L. Ramirez-Villar³, Carmen Saez^1,2,**, Enrique de Álava^1,2,**

¹ Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBERONC. Seville, Spain

² Pathology Unit, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, CIBERONC. Seville, Spain

³ Pediatric Oncology Unit, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain

* These authors contributed equally to this work as first authors

** These authors contributed equally to this work as senior authors